Your browser doesn't support javascript.
loading
Dynamic contrast-enhanced magnetic resonance imaging parameter changes as an early biomarker of tumor responses following radiation therapy in patients with spinal metastases: a systematic review.
Mulyadi, Rahmad; Putri, Pungky Permata; Handoko, Handoko; Zairinal, Ramdinal Aviesena; Prihartono, Joedo.
Afiliación
  • Mulyadi R; Department of Radiology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
  • Putri PP; Department of Radiology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
  • Handoko H; Department of Radiation Oncology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
  • Zairinal RA; Department of Neurology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
  • Prihartono J; Department of Community Medicine Pre Clinic, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
Radiat Oncol J ; 41(4): 225-236, 2023 Dec.
Article en En | MEDLINE | ID: mdl-38185927
ABSTRACT

PURPOSE:

This systematic review aims to assess and summarize the clinical values of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) parameter changes as early biomarkers of tumor responses following radiation therapy (RT) in patients with spinal metastases. MATERIALS AND

METHODS:

A systematic search was conducted on five electronic databases PubMed, Scopus, Science Direct, Cochrane, and Embase. Studies were included if they mentioned DCE-MRI parameter changes before and after RT in patients with spinal metastases with a correlation to tumor responses based on clinical and imaging criteria. The Quality Assessment of Diagnostic Accuracy Studies 2 was used to assess study quality.

RESULTS:

This systematic review included seven studies involving 107 patients. All seven studies evaluated the transfer constant (Ktrans), six studies evaluated the plasma volume fraction (Vp), three studies evaluated the extravascular extracellular space volume fraction, and two studies evaluated the rate constant. There were variations in the type of primary cancer, RT techniques used, post-treatment scan time, and median follow-up time. Despite the variations, however, the collected evidence generally suggested that significant differences could be detected in DCE-MRI parameters between before and after RT, which might reflect treatment success or failures in long-term follow-up. Responders showed higher reduction and lower values of Ktrans and Vp after RT. DCE-MRI parameters showed changes and detectable recurrences significantly earlier (up to 6 months) than conventional MRI with favorable diagnostic values.

CONCLUSION:

The results of this systematic review suggested that DCE-MRI parameter changes in patients with spinal metastases could be a promising tool for treatment-response assessment following RT. Lower values and higher reduction of Ktrans and Vp after treatment demonstrated good prediction of local control. Compared to conventional MRI, DCE-MRI showed more rapid changes and earlier prediction of treatment failure.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Systematic_reviews Idioma: En Revista: Radiat Oncol J Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Systematic_reviews Idioma: En Revista: Radiat Oncol J Año: 2023 Tipo del documento: Article